Dr. MartensCHIX:DOCSL +0.42%52 3-Year ROIIC % is 106.17 as of Mar. 2026, which is 575% above its 10-year median of 15.73. GuruFocus rates CHIX:DOCSL with a GF Score™ of 52/100 and a GF Value™ of £0.72 (Fairly Valued). The stock has 3 warning signs investors should review. Among 1,015 Manufacturing - Apparel & Accessories companies, Dr. Martens ranks better than 93.79% on this metric.
3-Year Return on Invested Incremental Capital (3-Year ROIIC %) measures the change in earnings as a percentage of change in investment over 3-year.
Dr. Martens's 3-Year ROIIC % for the quarter that ended in Mar. 2026 was 106.17%. High ROIIC is generally an indication that your business is capital efficient or has a higher operating leverage.
The industry rank for Dr. Martens's 3-Year ROIIC % or its related term are showing as below:
CHIX:DOCSl's 3-Year ROIIC % is ranked better than 93.79% of 1015
companies
in the Manufacturing - Apparel & Accessories industry
Industry Median: 1.46
vs CHIX:DOCSl: 106.17
Dr. Martens (CHIX:DOCSl) 3-Year ROIIC % Explanation
Return on Incremental Invested Capital (ROIIC) is an extension of Return on Investment Capital (ROIC). ROIC % tells investors how efficiently that profitability is earned per dollar of company capital. ROIIC narrows the focus even further and shows how profitable each additional unit of capital investment could be. ROIIC % is a more powerful metric than ROIC because it measures how much money the company can generate going forward on future capital investments.
High ROIIC is generally an indication that your business is capital efficient or has a higher operating leverage.
Be Aware
It's important to keep in mind that when tracking ROIIC, the metric is better suited to forecasting the trend of future returns rather than measuring current return on investment.
Dr. Martens 3-Year ROIIC % Related Terms
Dr. Martens 3-Year ROIIC % Historical Data
* Premium members only.
The historical data trend for Dr. Martens's 3-Year ROIIC % can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
CHIX:DOCSL vs NKE, DECK, ONON: 3-Year ROIIC % Comparison
For the Footwear & Accessories subindustry, Dr. Martens's 3-Year ROIIC %, along with its competitors' market caps and 3-Year ROIIC % data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Dr. Martens 3-Year ROIIC % vs Manufacturing - Apparel & Accessories Industry
For the Manufacturing - Apparel & Accessories industry and Consumer Cyclical sector, Dr. Martens's 3-Year ROIIC % distribution charts can be found below:
* The bar in red indicates where Dr. Martens's 3-Year ROIIC % falls into.
Dr. Martens's 3-Year ROIIC % for the quarter that ended in Mar. 2026 is calculated as:
3-Year ROIIC %
=
3-Year Incremental Net Operating Profit After Taxes (NOPAT)**
/
3-Year Incremental Invested Capital**
=
( 43.88634 (Mar. 2026) - 154.29996 (Mar. 2023) )
/
( 643.7 (Mar. 2026) - 747.7 (Mar. 2023) )
=
-110.41362
/
-104
=
106.17%***
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
** Annual data of NOPAT and Invested Capital was used to calculate 3-Year ROIIC %.
*** Please be aware that the ROIIC (Return on Invested Capital) calculations are based on company-level data using the primary share class. The calculated data provided is for demonstration purposes and may slightly differ from the results displayed in the title due to potential variations caused by currency exchange rate differences throughout the year.
Dr. Martens (CHIX:DOCSL) has a 3-Year ROIIC % of 106.17 as of Mar. 2026. 3-Year ROIIC % measures the change in earnings as a percentage of change in investment over 3-year. View historical data on Dr. Martens and its competitors. This is 575% above median its historical median of 15.73. According to the industry distribution chart, Dr. Martens ranks #63 out of 1015 companies in the Manufacturing - Apparel & Accessories industry, placing it in the top 6.2%.
Is Dr. Martens' 3-Year ROIIC % too high?
Dr. Martens' current 3-Year ROIIC % of 106.17 is 575% above median its 10-year median of 15.73. The Manufacturing - Apparel & Accessories industry median 3-Year ROIIC % is 1.46. Dr. Martens' value of 106.17 is 7171.9% above this industry median. Based on the distribution chart, Dr. Martens ranks #63 out of 1015 companies in the Manufacturing - Apparel & Accessories industry, which is in the top quartile — a strong position relative to peers. Overall, Dr. Martens has a GF Score™ of 52/100 and is considered Fairly Valued, reflecting its overall financial health beyond just this single metric.
How does Dr. Martens' 3-Year ROIIC % compare to NKE and DECK?
According to the Manufacturing - Apparel & Accessories industry distribution chart, Dr. Martens ranks #63 out of 1015 companies for 3-Year ROIIC %. This places Dr. Martens in the top 6% of its industry — outperforming the majority of peers. The industry median 3-Year ROIIC % is 1.46. Dr. Martens' value of 106.17 is 7171.9% above this benchmark. While the company's 10-year median is 15.73 vs. the industry median of 1.46, Dr. Martens has consistently been above the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good 3-Year ROIIC % for a Manufacturing - Apparel & Accessories company?
The median 3-Year ROIIC % among Manufacturing - Apparel & Accessories companies is 1.46, based on 1,015 companies in the industry. Companies in the top quartile (top 25%) have a 3-Year ROIIC % significantly above this median, while those in the bottom quartile fall well below. However, 3-Year ROIIC % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Dr. Martens's current 3-Year ROIIC % of 106.17 is 7171.9% above the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high 3-Year ROIIC % mean?
A high 3-Year ROIIC % can signal that a stock is expensive relative to its fundamentals. 3-Year ROIIC % measures the change in earnings as a percentage of change in investment over 3-year. View historical data on Dr. Martens and its competitors. For the Manufacturing - Apparel & Accessories industry, the median 3-Year ROIIC % is 1.46 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Dr. Martens's current 3-Year ROIIC % is 106.17, which is 575% above median its own 10-year median of 15.73. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Dr. Martens stock overvalued right now?
Based on GuruFocus' analysis, Dr. Martens (CHIX:DOCSL) is currently considered Fairly Valued. The stock's GF Value™ is £0.72, compared to a current price of £0.72 — trading 0.1% above its estimated fair value. The current 3-Year ROIIC % is 106.17, which is 575% above median its 10-year median of 15.73 and 7171.9% above the Manufacturing - Apparel & Accessories industry median of 1.46. Dr. Martens' overall GF Score™ is 52/100 with 3 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is 3-Year ROIIC % calculated?
3-Year ROIIC % is calculated from a company's financial statements. For Dr. Martens (CHIX:DOCSL), the current 3-Year ROIIC % is 106.17 as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Dr. Martens (CHIX:DOCSL) Overvalued in 2026?
Based on GuruFocus' analysis, Dr. Martens stock appears to be overvalued.
The current stock price of £0.72 is trading 0.1% above its estimated GF Value™ of £0.72.
GuruFocus considers Dr. Martens to be Fairly Valued.
Key valuation signals for CHIX:DOCSL:
3-Year ROIIC %: 106.17 (575% above median its 10-year median of 15.73)
GF Value™: £0.72 vs. price of £0.72 (0.1% above fair value)
Industry Position: 7171.9% above the Manufacturing - Apparel & Accessories median (#63 of 1015)
No single metric tells the full story. See the CHIX:DOCSL stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Dr. Martens PLC is engaged in the footwear business. Its product segments include Originals, Fusion, Kids and Casual, and a complementary range of Accessories. The company has sales through E-commerce, Retail, and Wholesale of Products. Geographically, it derives the majority of its revenue from EMEA and has a presence in the Americas and APAC.
52GF Score
Get the complete analysis for CHIX:DOCSL
3-Year ROIIC % is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
CHIX:DOCSL has been successfully added to your 
